S&P 500   3,785.00 (-0.16%)
DOW   30,303.14 (-0.04%)
QQQ   280.99 (-0.40%)
AAPL   145.80 (-0.21%)
MSFT   248.66 (-0.09%)
META   138.19 (-1.49%)
GOOGL   100.91 (-0.72%)
AMZN   120.26 (-0.69%)
TSLA   238.21 (-4.50%)
NVDA   130.73 (-0.71%)
NIO   15.87 (-5.14%)
BABA   84.22 (+0.13%)
AMD   67.36 (-0.80%)
T   15.94 (-0.93%)
MU   54.58 (+1.15%)
CGC   3.00 (-4.46%)
F   12.44 (+0.65%)
GE   67.55 (+0.01%)
DIS   99.96 (-1.46%)
AMC   7.26 (-7.28%)
PYPL   93.58 (+0.85%)
PFE   44.18 (-0.63%)
NFLX   234.77 (-2.48%)
S&P 500   3,785.00 (-0.16%)
DOW   30,303.14 (-0.04%)
QQQ   280.99 (-0.40%)
AAPL   145.80 (-0.21%)
MSFT   248.66 (-0.09%)
META   138.19 (-1.49%)
GOOGL   100.91 (-0.72%)
AMZN   120.26 (-0.69%)
TSLA   238.21 (-4.50%)
NVDA   130.73 (-0.71%)
NIO   15.87 (-5.14%)
BABA   84.22 (+0.13%)
AMD   67.36 (-0.80%)
T   15.94 (-0.93%)
MU   54.58 (+1.15%)
CGC   3.00 (-4.46%)
F   12.44 (+0.65%)
GE   67.55 (+0.01%)
DIS   99.96 (-1.46%)
AMC   7.26 (-7.28%)
PYPL   93.58 (+0.85%)
PFE   44.18 (-0.63%)
NFLX   234.77 (-2.48%)
S&P 500   3,785.00 (-0.16%)
DOW   30,303.14 (-0.04%)
QQQ   280.99 (-0.40%)
AAPL   145.80 (-0.21%)
MSFT   248.66 (-0.09%)
META   138.19 (-1.49%)
GOOGL   100.91 (-0.72%)
AMZN   120.26 (-0.69%)
TSLA   238.21 (-4.50%)
NVDA   130.73 (-0.71%)
NIO   15.87 (-5.14%)
BABA   84.22 (+0.13%)
AMD   67.36 (-0.80%)
T   15.94 (-0.93%)
MU   54.58 (+1.15%)
CGC   3.00 (-4.46%)
F   12.44 (+0.65%)
GE   67.55 (+0.01%)
DIS   99.96 (-1.46%)
AMC   7.26 (-7.28%)
PYPL   93.58 (+0.85%)
PFE   44.18 (-0.63%)
NFLX   234.77 (-2.48%)
S&P 500   3,785.00 (-0.16%)
DOW   30,303.14 (-0.04%)
QQQ   280.99 (-0.40%)
AAPL   145.80 (-0.21%)
MSFT   248.66 (-0.09%)
META   138.19 (-1.49%)
GOOGL   100.91 (-0.72%)
AMZN   120.26 (-0.69%)
TSLA   238.21 (-4.50%)
NVDA   130.73 (-0.71%)
NIO   15.87 (-5.14%)
BABA   84.22 (+0.13%)
AMD   67.36 (-0.80%)
T   15.94 (-0.93%)
MU   54.58 (+1.15%)
CGC   3.00 (-4.46%)
F   12.44 (+0.65%)
GE   67.55 (+0.01%)
DIS   99.96 (-1.46%)
AMC   7.26 (-7.28%)
PYPL   93.58 (+0.85%)
PFE   44.18 (-0.63%)
NFLX   234.77 (-2.48%)

ERYTECH Pharma - ERYP News Today

$0.60
+0.05 (+9.10%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.51
$0.63
50-Day Range
$0.54
$1.31
52-Week Range
$0.50
$6.44
Volume
20,677 shs
Average Volume
8,897 shs
Market Capitalization
$18.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get ERYTECH Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter.



ERYP Media Mentions By Week

ERYP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ERYP
News Sentiment

1.84

0.79

Average
Medical
News Sentiment

ERYP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ERYP Articles
This Week

1

1

ERYP Articles
Average Week

SourceHeadline
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
finance.yahoo.com - October 4 at 4:17 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Half of 2022
finanznachrichten.de - September 12 at 7:42 PM
finance.yahoo.com logoERYTECH Provides Business and Financial Update for the First Half of 2022
finance.yahoo.com - September 12 at 7:42 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital _August 31, 2022
finance.yahoo.com - September 6 at 9:28 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital _July 31, 2022
finance.yahoo.com - September 6 at 9:28 PM
finance.yahoo.com logoErytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%
finance.yahoo.com - August 26 at 4:00 PM
finance.yahoo.com logoErytech Pharma Culls Work On Late-Stage Leukemia Asset, Evaluates Partnership Options
finance.yahoo.com - August 25 at 9:45 AM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Provides Regulatory Update
finanznachrichten.de - August 24 at 6:43 PM
finance.yahoo.com logoERYTECH Provides Regulatory Update
finance.yahoo.com - August 24 at 6:43 PM
uk.finance.yahoo.com logoERYTECH Pharma S.A. (ERYP)
uk.finance.yahoo.com - July 15 at 12:01 AM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital _June 30, 2022.
finance.yahoo.com - July 7 at 6:15 PM
finance.yahoo.com logoReport – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022
finance.yahoo.com - June 24 at 5:50 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital _May 31, 2022.
finance.yahoo.com - June 3 at 3:07 PM
finance.yahoo.com logoERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022
finance.yahoo.com - May 24 at 8:49 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH to Present at the H.C. Wainwright Global Investment Conference
finanznachrichten.de - May 17 at 6:02 PM
finance.yahoo.com logoERYTECH to Present at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 17 at 6:02 PM
seekingalpha.com logoERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 13 at 5:49 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
finance.yahoo.com - May 13 at 5:49 PM
nz.finance.yahoo.com logoERYTECH Provides Business and Financial Update for the First Quarter of 2022
nz.finance.yahoo.com - May 12 at 6:00 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Quarter of 2022
finanznachrichten.de - May 12 at 6:00 PM
seekingalpha.com logoErytech Pharma reports Q1 results
seekingalpha.com - May 12 at 6:00 PM
finance.yahoo.com logoERYTECH Provides Business and Financial Update for the First Quarter of 2022
finance.yahoo.com - May 12 at 6:00 PM
finance.yahoo.com logoERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
finance.yahoo.com - April 28 at 6:22 PM
seekingalpha.com logoNkarta, ERYTECH Pharma top healthcare gainers; Eliem, Clarus lead losers' pack
seekingalpha.com - April 27 at 8:12 AM
investorplace.com logoWhy Is ERYTECH Pharma (ERYP) Stock Up Today?
investorplace.com - April 25 at 5:04 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent
finanznachrichten.de - April 25 at 8:51 AM
finance.yahoo.com logoERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
finance.yahoo.com - April 6 at 4:47 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital – March 31, 2022
finance.yahoo.com - April 6 at 4:47 PM
finance.yahoo.com logoERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
finance.yahoo.com - April 6 at 4:47 PM
apnews.com logoERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society
apnews.com - April 4 at 3:35 AM
finance.yahoo.com logoERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society
finance.yahoo.com - April 4 at 3:35 AM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH to Participate in the Upcoming April Investor Conferences
finanznachrichten.de - March 28 at 4:33 PM
finance.yahoo.com logoERYTECH to Participate in the Upcoming April Investor Conferences
finance.yahoo.com - March 28 at 4:33 PM
seekingalpha.com logoERYTECH Pharma S.A. 2021 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 14 at 10:55 AM
seekingalpha.com logoErytech Pharma reports Q4 results
seekingalpha.com - March 14 at 1:50 AM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
finanznachrichten.de - March 13 at 8:44 PM
finance.yahoo.com logoERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
finance.yahoo.com - March 11 at 6:08 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
finance.yahoo.com - March 4 at 3:48 PM
finance.yahoo.com logoErytech Shares Gain After Expanding Patent Portfolio For Treatment Of Rare Metabolic Diseases
finance.yahoo.com - February 9 at 8:24 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
finanznachrichten.de - February 8 at 6:28 PM
finance.yahoo.com logoERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
finance.yahoo.com - February 8 at 6:28 PM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
finance.yahoo.com - February 8 at 1:28 PM
finanznachrichten.de logoErytech Pharma S.A.: ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
finanznachrichten.de - January 24 at 8:47 AM
nasdaq.com logoERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
nasdaq.com - January 24 at 8:47 AM
seekingalpha.com logoErytech reports results of two eryaspase trials in pancreatic cancer at ASCO GI 2022
seekingalpha.com - January 24 at 8:47 AM
nasdaq.com logoErytech Pharma S.A. American Depositary Shares (ERYP)
nasdaq.com - January 16 at 12:50 AM
finance.yahoo.com logoMonthly information related to total number of voting rights and shares composing the share capital – December 31, 2021
finance.yahoo.com - January 10 at 12:28 PM
finance.yahoo.com logoERYTECH to Participate in the Upcoming January Virtual Investor Conferences
finance.yahoo.com - January 3 at 5:47 PM
finance.yahoo.com logoERYTECH Announces $7.85 Million Registered Direct Offering
finance.yahoo.com - December 14 at 1:59 PM
finance.yahoo.com logoERYTECH Announces $7.85 Million Registered Direct Offering
finance.yahoo.com - December 14 at 8:58 AM
Get ERYTECH Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ERYP) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.